Sleeping Aids Market Drivers are Responsible to for Increasing Market Share, Forecast 2026 Sleeping Aids Market - by Product Type (Drugs, Sleep Apnea Devices, and Mattresses and Pillows) and by Disorder (Insomnia, Sleep Apnea, Narcolepsy, Sleep Walking, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Click To Read More on Sleeping Aids Market Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment of sleeping disorders. However, various behavioral therapies such as light therapy, cognitive behavioral therapy, and relaxation techniques are also used in the treatment of these disorders. According to Centers for Disease Control and Prevention (CDC), in 2017, around 49.2 million people across the globe have trouble focusing due to lack of sleep. Rising incidences of insomnia is expected to fuel growth of the sleeping aids market One of the major factors contributing to growth of the sleeping aids market is the rising number of insomnia cases. According to the Centers for Disease Control and Prevention (CDC), in 2016, around 70 million adults suffered from insomnia in the U.S., with men reporting a higher rate of insomnia cases. Moreover, increasing geriatric population, changing life style with increase in consumption of alcohol, caffeine, and smoking, are some other factors leading to sleeping disorders. For instance, caffeine blocks the effectiveness of adenosine, a chemical that helps to bring on drowsiness and to regulate the sleep wake cycles. Sleeping Aids Market Taxonomy On the basis of treatment, the global sleeping aids market is segmented into: •Drug Type •Prescription-based Drugs •Over-the-counter Drugs •Herbal Drugs •Sleep Apnea Devices •Positive Airway Pressure (PAP) Devices •Adaptive Servo-ventilation (ASV) •Oxygen Concentrators •Oral Appliance •Others •Mattresses and Pillows On the basis of disorders, the global sleeping aids market is segmented into: •Insomnia •Sleep Apnea •Narcolepsy •Sleep Walking •Others On the basis of geography, the global sleeping aids market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held the dominant position in the global sleeping aids market in 2016. This is attributed to rising number of sleep apnea disorders, which is a chronic disease that increases the risk of heart diseases, high blood pressure, depression, and diabetes. For instance, according to American Academy of Sleep Medicine, in 2014, around 25 million people were affected with sleep apnea disorder in the U.S. Furthermore, Asia Pacific is expected to be the fastest growing region in the global sleeping aids market, owing to rising demand for sleeping pills due to stressful modern lifestyle. For instance, according to the Food and Drug Administration (FDA) in 2014, in Japan around 339 million sleeping pills were sold and the three most common drugs sold for the treatment of insomnia were Zolpidem (137.09 million pills), Estazolam (86.08 million pills) and Zopiclone (28.74 million pills) Ask For Sample Copy Of This Report : https://www.coherentmarketinsights.com/insight/requestsample/1059 Strategic partnerships among key players to deliver expert solutions for sleep apnea detection is expected to propel the market growth Major players operating in the global sleeping aids market include Itamar Medical, SleepMed Inc, Teva Pharmaceutical Industries Ltd., Cadwell Laboratories Inc., and Drive Medical Ltd. Key players are focusing on strategic mergers and acquisition for development of novel products in order to provide better care for sleep disorders. For instance, in August 2017, SleepMed Inc. announced its plans to enter into partnership with Early Sense, the inventor of Early Sense live, a sleep monitor that shares precise data with users about their sleep cycles. The objective of this partnership was to develop a sensor that can be used for monitoring disruptions throughout the night, including detection of interrupted breathing, heart rate, sleep cycles, and stress levels. The partnership will provide a comprehensive solution to its customers enabling better diagnosis and therapy. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1–206–701–6702 Email: [email protected]

Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Click To Read More on Sleeping Aids Market